Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Venlafaxine for Meniere's Disease
NCT04218123Phase 3Completed
- Sponsor
- Medical University of South Carolina
- Start
- Feb 2020
- Primary completion
- Sep 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of venlafaxine in Meniere's disease (MD), sponsored by Medical University of South Carolina. Started Feb 2020; status: completed.
02
Drugs
venlafaxine
03
Conditions
Meniere's disease (MD)
Beyond the preview
Go deeper on NCT04218123.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04218123.